News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
844,141 Results
Type
Article (86239)
Company Profile (651)
Press Release (757251)
Multimedia
Podcasts (129)
Webinars (14)
Section
Business (232510)
Career Advice (4125)
Deals (39716)
Drug Delivery (127)
Drug Development (90881)
Employer Resources (198)
FDA (18050)
Job Trends (17328)
News (396073)
Policy (39699)
Tag
Academia (2998)
Academic (1)
Accelerated approval (6)
Adcomms (25)
Allergies (86)
Alliances (56791)
ALS (94)
Alzheimer's disease (1490)
Antibody-drug conjugate (ADC) (144)
Approvals (18036)
Artificial intelligence (300)
Autoimmune disease (28)
Automation (16)
Bankruptcy (403)
Best Places to Work (12606)
BIOSECURE Act (22)
Biosimilars (119)
Biotechnology (448)
Bladder cancer (80)
Brain cancer (28)
Breast cancer (280)
Cancer (2293)
Cardiovascular disease (184)
Career advice (3532)
Career pathing (34)
CAR-T (168)
Cell therapy (470)
Cervical cancer (18)
Clinical research (73212)
Collaboration (886)
Company closure (1)
Compensation (505)
Complete response letters (29)
COVID-19 (2860)
CRISPR (48)
C-suite (251)
Cystic fibrosis (104)
Data (2193)
Decentralized trials (2)
Denatured (45)
Depression (53)
Diabetes (252)
Diagnostics (6894)
Digital health (19)
Diversity (9)
Diversity, equity & inclusion (48)
Drug discovery (130)
Drug pricing (102)
Drug shortages (21)
Duchenne muscular dystrophy (94)
Earnings (96357)
Editorial (40)
Employer branding (25)
Employer resources (167)
Events (129561)
Executive appointments (739)
FDA (19318)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (789)
Gene editing (114)
Generative AI (28)
Gene therapy (350)
GLP-1 (784)
Government (5124)
Grass and pollen (4)
Guidances (63)
Healthcare (20830)
Huntington's disease (25)
IgA nephropathy (31)
Immunology and inflammation (137)
Indications (29)
Infectious disease (2996)
Inflammatory bowel disease (153)
Inflation Reduction Act (11)
Influenza (51)
Intellectual property (96)
Interviews (812)
IPO (17788)
IRA (39)
Job creations (5187)
Job search strategy (2861)
Kidney cancer (11)
Labor market (42)
Layoffs (548)
Leadership (22)
Legal (10086)
Liver cancer (79)
Lung cancer (328)
Lymphoma (150)
Machine learning (6)
Management (65)
Manufacturing (329)
MASH (72)
Medical device (14602)
Medtech (14607)
Mergers & acquisitions (22413)
Metabolic disorders (701)
Multiple sclerosis (83)
NASH (23)
Neurodegenerative disease (105)
Neuropsychiatric disorders (28)
Neuroscience (2062)
NextGen: Class of 2025 (7667)
Non-profit (5071)
Now hiring (40)
Obesity (367)
Opinion (273)
Ovarian cancer (73)
Pain (93)
Pancreatic cancer (81)
Parkinson's disease (151)
Partnered (22)
Patents (239)
Patient recruitment (111)
Peanut (49)
People (65187)
Pharmaceutical (133)
Pharmacy benefit managers (19)
Phase I (22614)
Phase II (31799)
Phase III (23948)
Pipeline (1210)
Policy (149)
Postmarket research (3545)
Preclinical (10196)
Press Release (72)
Prostate cancer (103)
Psychedelics (35)
Radiopharmaceuticals (265)
Rare diseases (406)
Real estate (7391)
Recruiting (75)
Regulatory (26688)
Reports (57)
Research institute (2651)
Resumes & cover letters (649)
Rett syndrome (5)
RNA editing (5)
RSV (44)
Schizophrenia (78)
Series A (141)
Series B (88)
Service/supplier (27)
Sickle cell disease (56)
Special edition (18)
Spinal muscular atrophy (164)
Sponsored (34)
Startups (4288)
State (2)
Stomach cancer (13)
Supply chain (61)
Tariffs (41)
The Weekly (82)
Vaccines (787)
Venture capitalists (43)
Weight loss (258)
Women's health (39)
Worklife (20)
Date
Today (135)
Last 7 days (900)
Last 30 days (2675)
Last 365 days (33603)
2025 (10905)
2024 (36914)
2023 (42568)
2022 (53928)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1270)
Alabama (58)
Alaska (7)
Arizona (258)
Arkansas (13)
Asia (50089)
Australia (8825)
California (6207)
Canada (1960)
China (554)
Colorado (266)
Connecticut (285)
Delaware (154)
Europe (114758)
Florida (857)
Georgia (191)
Hawaii (1)
Idaho (64)
Illinois (568)
India (30)
Indiana (317)
Iowa (12)
Japan (165)
Kansas (111)
Kentucky (21)
Louisiana (14)
Maine (65)
Maryland (932)
Massachusetts (4767)
Michigan (230)
Minnesota (406)
Mississippi (2)
Missouri (84)
Montana (30)
Nebraska (26)
Nevada (63)
New Hampshire (69)
New Jersey (1759)
New Mexico (29)
New York (1748)
North Carolina (1087)
North Dakota (9)
Northern California (2660)
Ohio (199)
Oklahoma (14)
Oregon (46)
Pennsylvania (1364)
Puerto Rico (13)
Rhode Island (34)
South America (1650)
South Carolina (23)
South Dakota (1)
Southern California (2298)
Tennessee (86)
Texas (911)
United States (23614)
Utah (169)
Virginia (153)
Washington D.C. (56)
Washington State (583)
West Virginia (3)
Wisconsin (57)
844,141 Results for "bio technology general ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
bluebird bio confirms that Ayrmid, Ltd. has not delivered a binding offer or obtained necessary financing despite extensive engagement
April 16, 2025
·
10 min read
Neuroscience
GSK Dives Deeper Into Neuro With $2.5B+ ABL Bio Pact
GSK is paying to access ABL Bio’s Grabody-B platform, which potentially enables therapies to cross the blood-brain barrier.
April 7, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Ability Biotherapeutics Moves to Inspire Bio Innovations in Montreal, Pioneering the New Generation of Targeted Antibodies
April 29, 2025
·
4 min read
Press Releases
CD8 Technology Signs Letter of Intent for Tevogen Bio’s In-House Manufacturing Facility, Marking First Phase of Up to $50 Million Commitment
May 1, 2025
·
3 min read
Press Releases
Tenpoint Therapeutics Ltd. to Participate at Citi Biotech Private Access Day
April 23, 2025
·
1 min read
Press Releases
INmune Bio Receives Favorable Patentability Opinion for CORDStrom™ Platform Technology
April 16, 2025
·
5 min read
Press Releases
Generation Bio to Present at the Needham 24th Annual Virtual Healthcare Conference
April 2, 2025
·
1 min read
Press Releases
Nuvation Bio to Present at the Jones Healthcare and Technology Innovation Conference
April 2, 2025
·
1 min read
Notice of Annual General Meeting (AGM) of Bioretec Ltd
The shareholders of Bioretec Ltd are hereby invited to the Annual General Meeting to be held on 26 April 2024 at 10:00 a.m.
April 5, 2024
·
14 min read
Press Releases
Delve Bio to Present on Metagenomic Next Generation Sequencing (mNGS) at the American Academy of Neurology 2025 Annual Meeting
April 7, 2025
·
3 min read
1 of 84,415
Next
